The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Diabetes Drug Therapy-Global Market Insights and Sales Trends 2025
Synopsis
Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.
The global Diabetes Drug Therapy market size is expected to reach US$ 19490 million by 2029, growing at a CAGR of 10.0% from 2023 to 2029. The market is mainly driven by the significant applications of Diabetes Drug Therapy in various end use industries. The expanding demands from the Online Pharmacies, Hospital Pharmacies and Retail Pharmacies,, are propelling Diabetes Drug Therapy market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Subcutaneous segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetes Drug Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetes Drug Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetes Drug Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetes Drug Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetes Drug Therapy covered in this report include Abbott Laboratories, Mannkind Corporation, Bristol Myers Squibb, Medtronic, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Sanofi and Novo Nordisk, etc.
The global Diabetes Drug Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Mannkind Corporation
Bristol Myers Squibb
Medtronic
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Novo Nordisk
Novartis International AG
Global Diabetes Drug Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Drug Therapy market, Segment by Type:
Oral
Subcutaneous
Intravenous
Global Diabetes Drug Therapy market, by Application
Online Pharmacies
Hospital Pharmacies
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diabetes Drug Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.
The global Diabetes Drug Therapy market size is expected to reach US$ 19490 million by 2029, growing at a CAGR of 10.0% from 2023 to 2029. The market is mainly driven by the significant applications of Diabetes Drug Therapy in various end use industries. The expanding demands from the Online Pharmacies, Hospital Pharmacies and Retail Pharmacies,, are propelling Diabetes Drug Therapy market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Subcutaneous segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetes Drug Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetes Drug Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetes Drug Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetes Drug Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetes Drug Therapy covered in this report include Abbott Laboratories, Mannkind Corporation, Bristol Myers Squibb, Medtronic, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Sanofi and Novo Nordisk, etc.
The global Diabetes Drug Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Mannkind Corporation
Bristol Myers Squibb
Medtronic
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Novo Nordisk
Novartis International AG
Global Diabetes Drug Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Drug Therapy market, Segment by Type:
Oral
Subcutaneous
Intravenous
Global Diabetes Drug Therapy market, by Application
Online Pharmacies
Hospital Pharmacies
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diabetes Drug Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Diabetes Drug Therapy
1.1 Diabetes Drug Therapy Market Overview
1.1.1 Diabetes Drug Therapy Product Scope
1.1.2 Diabetes Drug Therapy Market Status and Outlook
1.2 Global Diabetes Drug Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Diabetes Drug Therapy Market Size by Region (2018-2029)
1.4 Global Diabetes Drug Therapy Historic Market Size by Region (2018-2023)
1.5 Global Diabetes Drug Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Diabetes Drug Therapy Market Size (2018-2029)
1.6.1 North America Diabetes Drug Therapy Market Size (2018-2029)
1.6.2 Europe Diabetes Drug Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Diabetes Drug Therapy Market Size (2018-2029)
1.6.4 Latin America Diabetes Drug Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Diabetes Drug Therapy Market Size (2018-2029)
2 Diabetes Drug Therapy Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Subcutaneous
2.1.3 Intravenous
2.2 Global Diabetes Drug Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Diabetes Drug Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Diabetes Drug Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Diabetes Drug Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Diabetes Drug Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Diabetes Drug Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Diabetes Drug Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Diabetes Drug Therapy Revenue Breakdown by Type (2018-2029)
3 Diabetes Drug Therapy Market Overview by Application
3.1 Introduction
3.1.1 Online Pharmacies
3.1.2 Hospital Pharmacies
3.1.3 Retail Pharmacies
3.2 Global Diabetes Drug Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Diabetes Drug Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Diabetes Drug Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Diabetes Drug Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Diabetes Drug Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Diabetes Drug Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Diabetes Drug Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Diabetes Drug Therapy Revenue Breakdown by Application (2018-2029)
4 Diabetes Drug Therapy Competition Analysis by Players
4.1 Global Diabetes Drug Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Drug Therapy as of 2022)
4.3 Date of Key Players Enter into Diabetes Drug Therapy Market
4.4 Global Top Players Diabetes Drug Therapy Headquarters and Area Served
4.5 Key Players Diabetes Drug Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Diabetes Drug Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Diabetes Drug Therapy Products, Services and Solutions
5.1.4 Abbott Laboratories Diabetes Drug Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Mannkind Corporation
5.2.1 Mannkind Corporation Profile
5.2.2 Mannkind Corporation Main Business
5.2.3 Mannkind Corporation Diabetes Drug Therapy Products, Services and Solutions
5.2.4 Mannkind Corporation Diabetes Drug Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Mannkind Corporation Recent Developments
5.3 Bristol Myers Squibb
5.3.1 Bristol Myers Squibb Profile
5.3.2 Bristol Myers Squibb Main Business
5.3.3 Bristol Myers Squibb Diabetes Drug Therapy Products, Services and Solutions
5.3.4 Bristol Myers Squibb Diabetes Drug Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Medtronic Recent Developments
5.4 Medtronic
5.4.1 Medtronic Profile
5.4.2 Medtronic Main Business
5.4.3 Medtronic Diabetes Drug Therapy Products, Services and Solutions
5.4.4 Medtronic Diabetes Drug Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Medtronic Recent Developments
5.5 AstraZeneca
5.5.1 AstraZeneca Profile
5.5.2 AstraZeneca Main Business
5.5.3 AstraZeneca Diabetes Drug Therapy Products, Services and Solutions
5.5.4 AstraZeneca Diabetes Drug Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 AstraZeneca Recent Developments
5.6 Eli Lilly and Company
5.6.1 Eli Lilly and Company Profile
5.6.2 Eli Lilly and Company Main Business
5.6.3 Eli Lilly and Company Diabetes Drug Therapy Products, Services and Solutions
5.6.4 Eli Lilly and Company Diabetes Drug Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly and Company Recent Developments
5.7 GlaxoSmithKline
5.7.1 GlaxoSmithKline Profile
5.7.2 GlaxoSmithKline Main Business
5.7.3 GlaxoSmithKline Diabetes Drug Therapy Products, Services and Solutions
5.7.4 GlaxoSmithKline Diabetes Drug Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 GlaxoSmithKline Recent Developments
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business
5.8.3 Sanofi Diabetes Drug Therapy Products, Services and Solutions
5.8.4 Sanofi Diabetes Drug Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Recent Developments
5.9 Novo Nordisk
5.9.1 Novo Nordisk Profile
5.9.2 Novo Nordisk Main Business
5.9.3 Novo Nordisk Diabetes Drug Therapy Products, Services and Solutions
5.9.4 Novo Nordisk Diabetes Drug Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Novo Nordisk Recent Developments
5.10 Novartis International AG
5.10.1 Novartis International AG Profile
5.10.2 Novartis International AG Main Business
5.10.3 Novartis International AG Diabetes Drug Therapy Products, Services and Solutions
5.10.4 Novartis International AG Diabetes Drug Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Novartis International AG Recent Developments
6 North America
6.1 North America Diabetes Drug Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Diabetes Drug Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Drug Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Diabetes Drug Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Drug Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Diabetes Drug Therapy Market Dynamics
11.1 Diabetes Drug Therapy Industry Trends
11.2 Diabetes Drug Therapy Market Drivers
11.3 Diabetes Drug Therapy Market Challenges
11.4 Diabetes Drug Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
